The drug approval process at the Food and Drug Administration. New biotechnology as a paradigm of a science-based activist approach.
Miller
H I
HI
Food and Drug Administration, Rockville, Md. 20857.
Young
F E
FE
D001709:Biotechnology; D002986:Clinical Trials as Topic; D004274:DNA, Recombinant; D004341:Drug Evaluation / Q000379:methods*; D004345:Drug Industry; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration*
D004274:DNA, Recombinant